CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹21 Cr | ₹-55 Cr | ₹-109 Cr | ₹-146 Cr | ₹129 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CIPLA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹-55 Cr |
| Mar2023 | ₹-109 Cr |
| Mar2022 | ₹-146 Cr |
| Mar2021 | ₹129 Cr |
How is Net Cash Inflow / Outflow of CIPLA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹21 Cr | Positive | |
| Mar2024 | ₹-55 Cr | Negative | |
| Mar2023 | ₹-109 Cr | Negative | |
| Mar2022 | ₹-146 Cr | Negative | |
| Mar2021 | ₹129 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹99,420.0 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,243.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,179.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,670.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,932.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| MANKIND PHARMA | ₹86,888.0 Cr | 2.5% | -4.7% | -9.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.5% |
-7.1% |
-14.4% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses